Clinical Trials Directory

Trials / Completed

CompletedNCT02032771

Impact of M22 Synergistic Sequential Treatment (SST)

Impact of M22 Synergistic Sequential Treatment (SST) Using Intense Pulsed Light and Fractional Non-ablative Photothermolysis on Skin Texture

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Lumenis Be Ltd. · Industry
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

Up to 40 healthy subjects at 2 sites, age 30-65 year old with Fitzpatrick-Elastosis score of 3-6 and mild to moderate age/sun-related facial pigmentation that wish to improve their facial skin appearance. Hypothesis: The SST will improve the appearance of the wrinkles/elastosis and/or pigmentation by at least 1 on the FES scale or ≥50% in category scale at 3 months follow-ups in at least 50% of the study population.

Conditions

Interventions

TypeNameDescription
DEVICEM22 IPL and ResurFXThe procedure will include an intense pulse light (M22 IPL) treatment followed by fractional non-ablative (M22 ResurFX) treatment.

Timeline

Start date
2014-01-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2014-01-10
Last updated
2016-09-16

Locations

2 sites across 2 countries: United States, Germany

Source: ClinicalTrials.gov record NCT02032771. Inclusion in this directory is not an endorsement.

Impact of M22 Synergistic Sequential Treatment (SST) (NCT02032771) · Clinical Trials Directory